Effects induced by inhibitors of the phosphatidylinositol 3-kinase/Akt and nitric oxide synthase/guanylyl cyclase pathways on the isometric contraction in rat aorta: A comparative study

Fundamental and Clinical Pharmacology

Volumn 25, Issue 3, 2011, Pages 313-322

  López, Ruth M ^a   Pérez, Teresa ^a   Castillo, Carlos ^b   Castillo, Enrique F ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Nitric oxide synthase; Phosphoinositide 3 kinase; Rat aorta

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POTASSIUM ION; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; WORTMANNIN;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; SYNTHESIS; VASCULAR RING; WISTAR RAT;

ANDROSTADIENES; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CHROMONES; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; ISOMETRIC CONTRACTION; MALE; MORPHOLINES; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXADIAZOLES; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3-KINASE; POTASSIUM; PROTO-ONCOGENE PROTEINS C-AKT; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 79954595043     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00833.x     Document Type: Article

References (37)

1. Morello F., Perino A., Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc. Res. (2009) 82 261-271.
2. 2+ channels. Circ. Res. (2001) 89 692-699.
3. Quignard J.F., Mironneau J., Carricaburu V. et al. Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. J. Biol. Chem. (2001) 276 32545-32551.
4. Komalavilas P., Mehta S., Wingard C.J. et al. PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways. J. Appl. Physiol. (2001) 91 1819-1827.
5. Su X., Smolock E.M., Marcel K.N., Moreland R.S. Phosphatidylinositol 3-kinase modulates vascular smooth muscle contraction by calcium and myosin light chain phosphorylation-independent and -dependent pathways. Am. J. Physiol. Heart Circ. Physiol. (2004) 286 H657-H666.
6. Shiojima I., Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. (2002) 90 1243-1250.
7. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (1999) 399 601-605.
8. Huang A., Sun D., Wu Z. et al. Estrogen elicits cytochrome P450-mediated flow-induced dilation of arterioles in NO deficiency: role of PI3K-Akt phosphorylation in genomic regulation. Circ. Res. (2004) 94 245-252.
9. Hisamoto K., Ohmichi M., Kurachi H. et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J. Biol. Chem. (2001) 276 3459-3467.
10. Gerber H.P., McMurtrey A., Kowalski J. et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway: requirement for Flk-1/KDR activation. J. Biol. Chem. (1998) 273 30336-30343.
11. Zeng G., Nystrom F.H., Ravichandran L.V. et al. Roles for insulin receptor, PI3-kinase and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation (2000) 101 1539-1545.
12. Budzyn K., Marley P.D., Sobey C.G. Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension. J. Pharmacol. Exp. Ther. (2005) 313 1248-1253.
13. Godfraind T., Egleme C., Al Osachie I. Role of endothelium in the contractile response of rat aorta to α-adrenoceptor agonists. Clin. Sci. (1985) 68 65s-71s.
14. Eglème C., Godfraind T., Miller R.C. Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells. Br. J. Pharmacol. (1984) 81 16-18.
15. 2-adrenergic agonist-induced vasoconstriction by removal of endothelium in rat aorta. J. Pharmacol. Exp. Ther. (1985) 232 682-687.
16. Bullock G.R., Taylor S.G., Weston A.H. Influence of the vascular endothelium on agonist-induced contractions and relaxations in rat aorta. Br. J. Pharmacol. (1986) 89 819-830.
17. Kaneko K., Sunano S. Involvement of α-adrenoceptors in the endothelium-dependent depression of noradrenaline-induced contraction in rat aorta. Eur. J. Pharmacol. (1993) 240 195-200.
18. Murakami K., Karaki H., Urakawa N. Role of endothelium in the contractions induced by norepinephrine and clonidine in rat aorta. Jpn. J. Pharmacol. (1985) 39 357-364.
19. Martin W., Furchgott R.F., Villani G.M., Jothianandan D. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther. (1986) 237 529-538.
20. Fleming I., Bauersachs J., Schafer A., Scholz D., Aldershvile J., Busse R. Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA (1999) 96 1123-1128.
21. Dora K.A., Doyle M.P., Duling B.R. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. Proc. Natl Acad. Sci. USA (1997) 94 6529-6534.
22. Dora K.A., Xia J., Duling B.R. Endothelial cell signaling during conducted vasomotor responses. Am. J. Physiol. Heart Circ. Physiol. (2003) 285 H1119-H1126.
23. Takano H., Dora K.A., Garland C.J. Spreading vasodilatation in resistance arteries. J. Smooth Muscle Res. (2005) 41 303-311.
24. Rezende B.A., Lemos V.S., Cortes S.F. Activation of nitric oxide modulator effect by isometric contraction in rat resistance arteries. J. Cardiovasc. Pharmacol. (2006) 47 51-54.
25. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. (1991) 43 109-142.
26. Pohl U., Wagner K., de Wit C. Endothelium-derived nitric oxide in the control of tissue perfusion and oxygen supply: physiological and pathophysiological implications. Eur. Heart J. (1993) 14 93-98.
27. Stauss H.M., Persson P.B. Role of Nitric Oxide in Buffering Short-Term Blood Pressure Fluctuations. News Physiol. Sci. (2000) 15 229-233.
28. Ignarro L.J. Biological actions and properties of endothelium derived nitric oxide formed and released from artery and vein. Circ. Res. (1989) 65 1-21.
29. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. (1994) 269 5241-5248.
30. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. (2000) 351 95-105.
31. Trembley J.H., Wang G., Unger G., Slaton J., Ahmed K. Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cell. Mol. Life Sci. (2009) 66 1858-1867.
32. Zhao Z., Leister W.H., Robinson R.G. et al. Discovery of 2, 3, 5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors. Bioorg. Med. Chem. Lett. (2005) 15 905-909.
33. Northcott C.A., Poy M.N., Najjar S.M., Watts S.W. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ. Res. (2002) 91 360-369.
34. Northcott C.A., Hayflick J., Watts S.W. Upregulated function of phosphatidylinositol-3-kinase in genetically hypertensive rats: a moderator of arterial hypercontractility. Clin. Exp. Pharmacol. Physiol. (2005) 32 851-858.
35. Safar M.E., Laurent P. Pulse pressure and arterial stiffness in rats: comparison with humans. Am. J. Physiol. Heart Circ. Physiol. (2003) 285 H1363-H1369.
36. Fitch R.M., Vergona R., Sullivan M.E., Wang Y.-X. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc. Res. (2001) 51 351-358.
37. Susic D., Varagic J., Frohlich E.D. Isolated systolic hypertension in elderly WKY is reversed with L-arginine and ACE inhibition. Hypertension (2001) 19 1422-1426.